RCM Eos Secures 9.99% Pulmatrix Stake Ahead of Merger

RCM Eos PIPE Holdings LLC invested $1 million to acquire a 9.99% stake in Pulmatrix, Inc. This strategic purchase of preferred stock precedes a planned merger where Pulmatrix will combine with Eos SENOLYTIX, Inc.

Pulmatrix, Inc., a biopharmaceutical company, received interim financing through this transaction. RCM Eos, associated with Eos SENOLYTIX, Inc.'s leadership, positioned itself strategically before the companies combine.

This investment involved RCM Eos PIPE Holdings LLC spending approximately $1 million. The funds secured 1,000 shares of Pulmatrix's Series B Convertible Preferred Stock, a security that often provides specific rights and can convert into common shares.

These 1,000 preferred shares convert into roughly 405,358 common shares. This conversion provides RCM Eos with a 9.99% beneficial ownership stake in Pulmatrix. This level of ownership also secures RCM Eos's commitment to vote its shares in favor of the impending merger.

The upcoming merger will significantly restructure ownership. Pre-merger Eos investors are set to hold approximately 94% of the combined company. Existing Pulmatrix shareholders will retain roughly 6% of the new entity.

This transaction signals a clear path towards the merger's completion and the subsequent shift in corporate direction. The combined company will operate under the business objectives and leadership of Eos SENOLYTIX, Inc.

Investors will now watch for the finalization of the merger and the strategic initiatives of the newly combined entity.